Literature DB >> 10435938

Raloxifene as a multifunctional medicine? Current trials will show whether it is effective in both osteoporosis and breast cancer.

V C Jordan, M Morrow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10435938      PMCID： PMC1126973          DOI： 10.1136/bmj.319.7206.331

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.

Authors:  P D Delmas; N H Bjarnason; B H Mitlak; A C Ravoux; A S Shah; W J Huster; M Draper; C Christiansen
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

Review 2.  Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.

Authors:  L J Lerner; V C Jordan
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

3.  Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.

Authors:  B W Walsh; L H Kuller; R A Wild; S Paul; M Farmer; J B Lawrence; A S Shah; P W Anderson
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

4.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

5.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

6.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

Authors:  S R Cummings; S Eckert; K A Krueger; D Grady; T J Powles; J A Cauley; L Norton; T Nickelsen; N H Bjarnason; M Morrow; M E Lippman; D Black; J E Glusman; A Costa; V C Jordan
Journal:  JAMA       Date:  1999-06-16       Impact factor: 56.272

7.  Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.

Authors:  R R Love; R B Mazess; H S Barden; S Epstein; P A Newcomb; V C Jordan; P P Carbone; D L DeMets
Journal:  N Engl J Med       Date:  1992-03-26       Impact factor: 91.245

8.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

9.  Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.

Authors:  M M Gottardis; V C Jordan
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

10.  A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

Authors:  T J Powles; J R Hardy; S E Ashley; G M Farrington; D Cosgrove; J B Davey; M Dowsett; J A McKinna; A G Nash; H D Sinnett
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
View more
  3 in total

Review 1.  Recent advances: rheumatology.

Authors:  R Madhok; H Kerr; H A Capell
Journal:  BMJ       Date:  2000-10-07

2.  Interactions of the human cytosolic sulfotransferases and steroid sulfatase in the metabolism of tibolone and raloxifene.

Authors:  Josie L Falany; Charles N Falany
Journal:  J Steroid Biochem Mol Biol       Date:  2007-06-26       Impact factor: 4.292

3.  A new day dawns: women without oestrogen or is a balance best?

Authors:  V Craig Jordan
Journal:  Breast Cancer Res       Date:  2002-09-10       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.